Alto Ingredients, Inc. ALTO
- Market cap
- $290.1M
- P/E
- 5.5×
Follow ALTO
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.41 | 4.10 | 0.76 | 0.39 | 0.22 | 4.39 | 2.61 | 1.20 | 1.18 | 0.76 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 10.95 | 10.05 | 4.75 | 1.67 | 11.44 | 8.34 | 7.37 | 4.97 | 2.80 | 3.18 |
High Price
|
|||
| 500 | 560 | 510 | 500 | 370 | 417 | 439 | 460 | 393 | 390 |
Employees
|
|||
| 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 2 |
Revenue/Emp
|
|||
| 1,625 | 1,632 | 1,515 | 1,425 | 897 | 1,208 | 1,336 | 1,223 | 965 | 918 |
Revenue
|
|||
| 3.35% | 0.36% | (1.00%) | (0.70%) | 5.89% | 5.61% | (2.06%) | 1.28% | 1.01% | 3.80% |
Gross Margin
|
|||
| 1 | (38) | (68) | (101) | (17) | 48 | (40) | (28) | (59) | 13 |
EBT
|
|||
| 0.03% | (2.35%) | (4.52%) | (7.11%) | (1.93%) | 3.94% | (2.97%) | (2.28%) | (6.09%) | 1.39% |
EBT Margin
|
|||
| 2 | (38) | (68) | (101) | (17) | 46 | (42) | (28) | (59) | 13 |
Net Income
|
|||
| 38 | 40 | 42 | 49 | 31 | 24 | 25 | 25 | 26 | 27 |
Depreciation
|
|||
| 38.52 | 38.19 | 34.94 | 30.07 | 15.31 | 16.99 | 18.56 | 16.68 | 13.14 | 12.32 |
Revenue/Sh
|
|||
| 0.00 | (0.85) | (1.42) | (1.90) | (0.28) | 0.62 | (0.60) | (0.40) | (0.82) | 0.16 |
Earnings/Sh
|
|||
| 0.88 | 0.85 | 0.04 | (0.66) | 1.22 | 0.38 | 0.08 | 0.30 | (0.05) | 0.18 |
Cash Flow/Sh
|
|||
| (0.45) | (0.49) | (0.35) | (0.07) | 0.06 | (0.23) | (0.52) | (0.40) | (0.15) | (0.06) |
Capex/Sh
|
|||
| 0.43 | 0.37 | (0.31) | (0.73) | 1.28 | 0.15 | (0.44) | (0.10) | (0.19) | 0.12 |
Free CF/Sh
|
|||
| 9.92 | 8.98 | 7.36 | 4.79 | 5.05 | 4.86 | 4.28 | 3.81 | 3.06 | 3.29 |
Book Value/Sh
|
|||
| 42 | 43 | 43 | 47 | 59 | 71 | 72 | 73 | 73 | 75 |
Shares
|
|||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.76 | 0.00 | 0.00 | 0.00 | 16.94 |
PE Ratio
|
|||
| 0.26 | 0.12 | 0.02 | 0.02 | 0.35 | 0.28 | 0.16 | 0.16 | 0.12 | 0.23 |
PS Ratio
|
|||
| 0.99 | 0.51 | 0.12 | 0.14 | 1.07 | 0.99 | 0.68 | 0.70 | 0.51 | 0.88 |
PB Ratio
|
|||
| 0.34 | 0.24 | 0.16 | 0.18 | 0.41 | 0.26 | 0.17 | 0.19 | 0.18 | 0.29 |
EV/Sales
|
|||
| 30.48 | 24.83 | (17.82) | (7.41) | 4.89 | 30.50 | (7.16) | (31.28) | (12.13) | 30.99 |
EV/FCF
|
|||
| 37 | 37 | 2 | (31) | 72 | 27 | 6 | 22 | (4) | 13 |
Op' Cash Flow
|
|||
| (19) | (21) | (15) | (3) | 3 | (16) | (38) | (30) | (11) | (5) |
Capex
|
|||
| 18 | 16 | (14) | (35) | 75 | 10 | (32) | (8) | (14) | 9 |
FCF
|
|||
| 156 | 113 | (63) | 72 | 127 | 160 | 121 | 103 | 95 | 97 |
Working Cap'
|
|||
| 199 | 241 | 231 | 244 | 97 | 54 | 72 | 82 | 93 | 80 |
Total Debt
|
|||
| 135 | 192 | 205 | 225 | 49 | (24) | 18 | 34 | 53 | 53 |
Net Debt
|
|||
| 418 | 384 | 319 | 227 | 296 | 345 | 308 | 280 | 225 | 245 |
Sh' Equity
|
|||
| 0.02% | (5.07%) | (8.92%) | (14.18%) | (3.01%) | 9.19% | (8.90%) | (6.28%) | (14.08%) | 3.06% |
ROA
|
|||
| 2.66% | (2.78%) | (6.15%) | (10.33%) | 1.78% | 7.79% | (11.77%) | (4.75%) | (11.60%) | 1.54% |
ROIC
|
|||
| 0.04% | (9.04%) | (17.51%) | (33.02%) | (6.26%) | 13.79% | (13.12%) | (9.96%) | (23.88%) | 5.13% |
ROE
|
|||
Alto Ingredients, Inc. peers in Specialty Chemicals
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| OEC Orion S.A. | $340.3M | 0.0× | Compare |
| GEVO Gevo, Inc. | $348.6M | 0.0× | Compare |
| FF FutureFuel Corp. | $225.5M | 0.0× | Compare |
| HDSN Hudson Technologies, Inc. | $220.1M | 24.8× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| MNTK Montauk Renewables, Inc. | $409.9M | 47.6× | Compare |
| CMT Core Molding Technologies Inc | $204.4M | 27.0× | Compare |
| AMTX Aemetis, Inc | $129.9M | 0.0× | Compare |
| MATV Mativ Holdings, Inc. | $671.7M | 7.4× | Compare |
Alto Ingredients, Inc. (ALTO) key facts
- Alto Ingredients, Inc. (ALTO) is a Specialty Chemicals company in the Basic Materials sector, listed on Nasdaq.
- Alto Ingredients, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $917.9 million, down 4.90% from fiscal 2024.
- Net income was $13.3 million, or $0.16 per share (basic), a net margin of 1.32%.
- As of September 25, 2026, ALTO traded at $3.73, a market capitalization of $290.1 million.
- At that price the stock trades at 5.5× trailing-twelve-month earnings and 0.3× sales.
- Return on equity was 5.13% and debt-to-equity 0.23.
Alto Ingredients, Inc. (ALTO) Latest News
24 Aug
Alto Ingredients questions ability to hold recent stock gains as alcohol product premiums narrow and pressure margins. Narrowing alcohol premiums may moderately affect Alto Ingredients margins and market trajectory.
17 Aug
Alto Ingredients faces export challenges that may weigh on its growth outlook. Export challenges may moderately affect Alto Ingredients' financial performance and market position.
14 Aug
Alto Ingredients reports Q2 earnings, prompting analysis on buy, hold or sell decisions for ALTO stock based on results and outlook. Q2 earnings release may affect near-term stock movement without shifting long-term trajectory.
13 Aug
Alto Ingredients Inc. held its Q2 2026 earnings call, covering financial results, operational updates and forward outlook for the company. Quarterly earnings call provides performance data and guidance that can shift near-term investor views without altering long-term strategy.
11 Aug
45Z tax credits may serve as next earnings driver for Alto Ingredients, Inc. Potential 45Z tax credits could moderately influence Alto Ingredients earnings without fundamentally shifting long-term trajectory.
6 Aug
Alto Ingredients posted a sharp Q2 EBITDA increase that signals a potential company turnaround. Q2 EBITDA surge points to improved financial trajectory and investor sentiment for ALTO.
Alto Ingredients Q2 earnings call noted margin recovery progress and prioritized strategic focus on 45Z initiatives. Q2 margin recovery and 45Z focus signal moderately positive effects on near-term financials and positioning.
5 Aug
Alto Ingredients (ALTO) posted Q2 earnings and revenues above analyst estimates. Quarterly earnings beat signals improved financial results without shifting long-term company trajectory.
Alto Ingredients Q2 earnings call covered financial results, operational updates and forward guidance for the company. Earnings call data typically shifts short-term market views via fresh financial metrics and outlook statements.
Alto Ingredients, Inc. reported its second quarter 2026 financial results. Quarterly earnings releases disclose financial metrics that influence valuation and market perception.
27 Jul
Alto Ingredients plans to monetize every ton of biogenic CO2 through capture, utilization and sales initiatives tied to its existing production operations. Monetization of biogenic CO2 constitutes a major strategic move that can materially improve revenue and competitive positioning.
20 Jul
Potential E15 adoption could unlock next growth phase for Alto Ingredients through higher ethanol demand. E15 adoption represents regulatory shift that could significantly boost Alto Ingredients ethanol sales.
16 Jul
ALTO trades at a discount despite 344% rally over the past year, raising questions on next price trajectory and valuation. Stock valuation discussion can shift near-term sentiment but does not alter core operations or fundamentals.
13 Jul
Alto Ingredients considers debottlenecking to launch its next growth phase. Debottlenecking offers operational gains that may moderately lift efficiency and growth outlook.
10 Jul
Alto Ingredients (ALTO) added to Russell indices while pursuing river logistics expansion, increasing index fund exposure and aiming to strengthen operational logistics for potential shareholder gains. Russell index additions increase passive investment flows while river logistics bet targets supply chain gains without altering core trajectory.
9 Jul
Alto Ingredients (ALTO) stock could be 35% undervalued following Russell Index inclusion. Russell Index inclusion typically draws institutional buying that can lift valuation and short-term trading volume for ALTO.
6 Jul
Alto Ingredients returned to profitability but questions remain on sustaining momentum amid ongoing market and operational pressures. Discussion of profitability sustainability may moderately affect investor sentiment toward ALTO shares.
2 Jul
Alto Ingredients is expanding production capacity at its Pekin facility. Pekin capacity expansion is a major strategic investment that can significantly increase output and improve market position.
29 Jun
Alto Ingredients considers biogenic CO2 capture and sales as potential new growth business alongside existing ethanol operations. Biogenic CO2 development represents major strategic expansion opportunity that could alter Alto Ingredients revenue trajectory.
Alto Ingredients, Inc. (ALTO) added to Russell 2000® and Russell 3000® Indexes. Index inclusion draws passive fund inflows and lifts trading liquidity without altering core operations.
26 Jun
H.C. Wainwright raised its price target on Alto Ingredients (ALTO) after the company returned to profitability. Analyst price target increase following profitability signals moderate positive sentiment shift without major operational changes.
22 Jun
Alto Ingredients earns more from each bushel of corn due to improved operational efficiencies. Higher earnings per bushel signal operational gains with moderate effects on financial results.
18 Jun
Alto Ingredients receives cash inflow from 45Z tax credit, indicating its stock could be 45% undervalued. 45Z tax credit cash inflow boosts ALTO financials and supports major upward revaluation of its shares.
16 Jun
Alto Ingredients (ALTO) shares rose 5.3% after monetizing 2025 clean fuel tax credits for cash. Immediate cash from future tax credits improves near-term liquidity without altering core long-term trajectory.
Alto Ingredients, Inc. (ALTO) stock has risen 374% over the past year. A 374% annual stock rise indicates strong recent performance with moderate ongoing influence on future sentiment and trading activity.
15 Jun
Alto Ingredients completed a transaction monetizing all 2025 45Z clean fuel production tax credits. Monetizing 2025 tax credits delivers substantial immediate cash flow to Alto Ingredients.
Alto Ingredients is accessing 45Z tax credits with the size of the resulting opportunity still undetermined. 45Z credit access can improve near-term cash flow but does not yet indicate a fundamental shift in operations or market position.
8 Jun
Strong export demand boosted Alto Ingredients' profitability. Export demand gains directly lifted revenue and margins for the company's core operations.
2 Jun
Alto Ingredients benefits from stronger returns in its essential ingredients segment, supporting improved financial results and operational performance. Stronger essential ingredients returns improve Alto Ingredients financial performance and market position.
11 May
Alto Ingredients (ALTO) upgraded to Strong Buy by analysts due to favorable factors outlined in the report. Analyst upgrade to Strong Buy enhances investor sentiment and could significantly boost stock performance.